The OCT New England conference brought together a number of high level professional from a number of pharma, biotech and medical device companies who work in operations and outsourcing in clinical trials. The event focused primarily on rare and orphan disease in 2016 with a popular panel discussion on the pharma and biotech stream on the second day; discussing strategic ways to conduct clinical trials to tackle this area.